VALERIE CHANG: Open Payments
NPI 1285820886 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,063 in 141 payments from 28 companies in 2025. Trend: 2023 $58 · 2024 $2,533 · 2025 $3,063
Food & beverage: $2,894Education: $169
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 54 | $678 |
| SOBI, INC | 7 | $293 |
| Janssen Biotech, Inc. | 7 | $244 |
| Merck Sharp & Dohme LLC | 8 | $200 |
| Exelixis Inc. | 5 | $192 |
| AstraZeneca Pharmaceuticals LP | 9 | $186 |
| PFIZER INC. | 7 | $174 |
| Regeneron Healthcare Solutions, Inc. | 5 | $168 |
| Incyte Corporation | 4 | $151 |
| Novartis Pharmaceuticals Corporation | 7 | $151 |
Products named: Enhertu, KEYTRUDA, CABOMETYX, Doptelet, LIBTAYO, RYBREVANT, DATROWAY, IMFINZI.
Industry payments across NV — which companies pay providers there.
